USA Herald August 19, 2026
Moderna and Merck Cancer Vaccine Meets Phase 3 Goals in Melanoma Trial
The Moderna and Merck cancer vaccine has met the main goals of a large Phase 3 melanoma trial, marking a…
USA Herald August 19, 2026
The Moderna and Merck cancer vaccine has met the main goals of a large Phase 3 melanoma trial, marking a…
By David Akinwale
America July 11, 2025
Pharmaceutical titan Merck & Co. Inc. has announced a landmark $10 billion acquisition of Verona Pharma plc, underscoring its strategy…
By Rihem Akkouche

